Borza I, Babes A. FECAL CALPROTECTIN DOSAGE VALUE AS A DIAGNOSTIC AND POSTOPERATIVE MARKER IN DIABETIC PATIENTS WITH COLORECTAL CANCER. RJDNMD [Internet]. 15Mar.2015 [cited 17Apr.2026];22(1):11-8. Available from: https://rjdnmd.org/index.php/RJDNMD/article/view/155